Status:
UNKNOWN
Meditation-Relaxation (MR Therapy) for Sleep Paralysis.
Lead Sponsor:
Azienda Usl di Bologna
Conditions:
Sleep Paralysis
Narcolepsy Type 1
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of the study is to evaluate, with a small-scale pilot study, the efficacy of Meditation Relaxation therapy for Sleep Paralyses in patients with narcolepsy. The study involves two arms, with in...
Eligibility Criteria
Inclusion
- Narcolepsy (type 1 and 2) based on polysomnography, Multiple Sleep Latency Test \[MLST\] and CSF hypocretin level testing).
- Patients had to have experienced SP at least four times in the last month.
Exclusion
- Psychiatric comorbidity.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04483310
Start Date
December 1 2018
End Date
December 31 2022
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda USL di Bologna
Bologna, Italy